Drug Type ASO |
Synonyms- |
Target |
Mechanism MIR181A2 antagonists(microRNA 181a-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chondrosarcoma | Preclinical | US | 24 Jul 2019 | |
Chondrosarcoma | Preclinical | US | 24 Jul 2019 | |
Chondrosarcoma | Preclinical | US | 24 Jul 2019 |